Income StatementBalance SheetCash FlowSegments
Viatris logo

Viatris Cash Flow Statement

Operating, investing, and financing cash movements

Viatris generated $2.2B in operating cash flow over the trailing twelve months. After $376.1M in capital expenditures, free cash flow was $1.8B. Free cash flow decreased 0.1% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$2.2BNet Cash From Investing (TTM)-$85.2MNet Cash From Financing (TTM)-$1.0BCapital Expenditures (TTM)$376.1MDepreciation And Amortization Cf (TTM)$2.8BNet Change In Cash (TTM)$1.0B
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$19.2B
ROE-1.96%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Other non-cash income (expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Change in accounts payable$45.7M$101.6M-$291.3M——$32.7M
Change in accounts receivable-$300.5M-$168.0M——-$271.9M$126.3M
Change in income taxes payable/receivable—-$120.6M-$246.0M——-$463.4M
Change in inventories$35.6M$193.7M$39.0M——$123.0M
Other working capital changes$88.3M$177.2M$396.4M$20.2M$39.9M$22.9M
Deferred income taxes-$248.9M-$43.6M-$47.5M-$137.2M-$248.2M-$69.7M
Depreciation and amortization$746.2M$664.7M$678.3M$688.5M$766.8M$676.1M
Impairment charges$0.0$2.9B$0.0$0.0$0.0$0.0
Other Non-Cash Income (Expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Other Non-cash Income (Expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Other Non-cash Income (Expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Net cash from operating activities$482.7M$535.5M$219.7M$744.9M$815.8M$388.3M
Net income-$516.5M-$3.0B-$4.6M-$128.2M-$340.1M$176.4M
Other non-cash income (expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Change in noncash litigation settlements, net-$28.9M$69.4M$27.6M——-$58.0M
Gain on sale of business and assets-$103.7M-$36.9M-$43.8M$0.0-$21.9M-$13.9M
Accounts payable$45.7M$101.6M-$291.3M——$32.7M
Other Noncash Income (Expense)—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Payments To Acquire In Process Research And Development, Other-$25.0M-$15.0M——-$35.8M-$6.0M
Other Non-cash Income and Expense—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Other Non-Cash Adjustments—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Other Non-Cash Income and Expense—-$203.8M-$522.5M-$109.5M-$133.5M-$182.3M
Stock-based compensation$32.3M$55.2M$37.1M$36.0M$49.4M$48.2M
Loss on Sale of Subsidiary-$103.7M-$36.9M-$43.8M$0.0-$21.9M-$13.9M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from Sales of Assets and Subsidiaries—$11.3M$1.6M$800.0K—$1.6M
Capital expenditures$140.4M$42.6M$52.9M$86.8M$196.5M$39.9M
Proceeds from Sale of Retained Ownership Interests—$0.0———$400.0M
Payment for (Proceeds from) Other Investing Activity$700.0K$18.8M$1.2M$12.9M$2.6M$82.0M
Purchases of IPR&D-$25.0M-$15.0M——-$35.8M-$2.3M
Proceeds from disposal of certain strategic investments—$0.0———$400.0M
Proceeds from disposition of property, plant and equipment/other—$11.3M$1.6M$800.0K—$1.6M
Proceeds from Sale of Seagen Inc. Common Stock—$0.0———$400.0M
Net cash from investing activities$0.0-$65.1M-$52.5M-$98.9M-$211.2M$277.4M
Other investing activities$700.0K$18.8M$1.2M$12.9M$2.6M$82.0M
Proceeds from maturities/sales of investments—$0.0———$400.0M
Proceeds from sale of businesses$0.0$0.0$0.0$0.0$2.5M$1.6M
Proceeds from sale of PPE and intangibles—$11.3M$1.6M$800.0K—$1.6M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Distributions to noncontrolling interests$143.3M$143.3M$139.8M$139.9M$138.2M$139.6M
Payments for Non-Contingent Consideration for Product Rights, Financing Activities$0.0$0.0$0.0$0.0$0.0—
Payments to Noncontrolling Interests$143.3M$143.3M$139.8M$139.9M$138.2M$139.6M
Other, net$98.3M-$109.6M-$45.4M-$23.1M-$12.0M-$300.0K
Proceeds from (Repayments of) Short-Term Debt-$1.5M$1.4M—$300.0K—$0.0
Payment of Deferred Purchase Consideration$98.3M-$109.6M-$45.4M-$23.1M-$12.0M-$300.0K
Noncontrolling interest transactions and other$98.3M-$109.6M-$45.4M-$23.1M-$12.0M-$300.0K
Net cash from financing activities-$1.4B-$467.0M-$362.4M-$228.1M-$236.4M-$203.8M
Other financing activities$98.3M-$109.6M-$45.4M-$23.1M-$12.0M-$300.0K
Noncontrolling Interests Activity and Other$98.3M-$109.6M-$45.4M-$23.1M-$12.0M-$300.0K
Proceeds from issuance of common stock$600.0K$600.0K$700.0K$700.0K$600.0K$500.0K
Repurchases of common stock—$175.4M$175.0M$67.9M$85.1M$0.0
Net change in short-term borrowings-$1.5M$1.4M—$300.0K—$0.0
Taxes paid for net share settlement$0.0$29.3M$200.0K$800.0K$0.0$56.5M
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries-$1.5M$1.4M—$300.0K—$0.0

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$342.3M$492.9M$166.8M$658.1M$619.3M$348.4M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$37.8M$16.8M$6.7M$17.8M—-$4.2M
Net increase (decrease) in cash-$1.1B$20.2M-$188.5M$435.7M$344.5M$457.7M
Payments Of Merger Related Costs Financing Activities—$11.4M$1.7M——$7.9M